Items where Author is "Aslani, M."

Up a level
Export as [feed] Atom [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | No Grouping
Jump to: Article
Number of items: 4.


Mortazavi-Jahromi, S. S. and Aslani, M. and Omidian, S. and Ahmadzadeh, A. and Rezaieyazdi, Z. and Mirshafiey, A. (2020) Immunopharmacological effect of β-d-mannuronic acid (M2000), as a new immunosuppressive drug, on gene expression of miR-155 and its target molecules (SOCS1, SHIP1) in a clinical trial on rheumatoid arthritis patients. Drug Development Research, 81 (3). pp. 295-304.

Mortazavi-Jahromi, S. S. and Ahmadzadeh, A. and Rezaieyazdi, Z. and Aslani, M. and Omidian, S. and Mirshafiey, A. (2020) The role of β-d-mannuronic acid, as a new non-steroidal anti-inflammatory drug on expression of miR-146a, IRAK1, TRAF6, NF-κB and pro-inflammatory cytokines following a clinical trial in rheumatoid arthritis patients. Immunopharmacology and Immunotoxicology, 42 (3). pp. 228-236.

Rezaieyazdi, Z. and Farooqi, A. and Soleymani-Salehabadi, H. and Ahmadzadeh, A. and Aslani, M. and Omidian, S. and Sadoughi, A. and Vahidi, Z. and Khodashahi, M. and Zamurrad, S. and Mortazavi-Jahromi, S. S. and Fallahzadeh, H. and Hosseini, M. and Aghazadeh, Z. and Ekhtiari, P. and Matsuo, H. and Rehm, B. H. A. and Cuzzocrea, S. and D’Aniello, A. and Mirshafiey, A. (2019) International multicenter randomized, placebo-controlled phase III clinical trial of β-d-mannuronic acid in rheumatoid arthritis patients. Inflammopharmacology, 27 (5). pp. 911-921.

Rasekh, H. R. and Hosseinzadeh, L. and Mehri, S. and Kamli-Nejad, M. and Aslani, M. and Tanbakoosazan, F. (2012) Safety assessment of ocimum basilicum hydroalcoholic extract in wistar rats: Acute and subchronic toxicity studies. Iranian Journal of Basic Medical Sciences, 15 (1). pp. 645-653.

This list was generated on Wed Apr 14 13:09:36 2021 EDT.